READCOOR
ReadCoor is a technology company offering the first true spatial multi-omic platform to the global audience of researchers, clinicians, pharma and diagnostics companies to expand understanding of human biology and to facilitate the creation of new therapeutics for patients. The company’s RC2 Platform simultaneously detects and reads the sequences of tens to thousands of RNA, DNA, proteins, and therapeutics and visualizes sub-cellular nanoscale 3D resolution in every cell throughout any tissue section. The Platform, based on ReadCoor’s proprietary Fluorescent in situ Sequencing (FISSEQ) technology, combines the massive multiplexity of next-generation sequencing (NGS) and high-resolution tissue imaging.
READCOOR
Industry:
Biotechnology Medical Pharmaceutical
Founded:
2016-09-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.readcoor.com
Total Employee:
11+
Status:
Closed
Contact:
(617)453-2660
Email Addresses:
[email protected]
Total Funding:
52.5 M USD
Technology used in webpage:
SPF Domain Not Resolving Microsoft Exchange Online Office 365 Mail IPv6 Google Apps For Business Cloudflare Hosting COVID-19 Cloudflare DNS MailChimp SPF
Current Advisors List
Current Employees Featured
Founder
Investors List
Decheng Capital
Decheng Capital investment in Series B - ReadCoor
Pavilion Capital
Pavilion Capital investment in Series B - ReadCoor
Hansjörg Wyss
Hansjörg Wyss investment in Series B - ReadCoor
Silicon Valley Community Foundation
Silicon Valley Community Foundation investment in Grant - ReadCoor
Chan Zuckerberg Initiative
Chan Zuckerberg Initiative investment in Grant - ReadCoor
Hansjörg Wyss
Hansjörg Wyss investment in Series A - ReadCoor
Lilly Asia Ventures
Lilly Asia Ventures investment in Series A - ReadCoor
Decheng Capital
Decheng Capital investment in Series A - ReadCoor
Vivo Capital
Vivo Capital investment in Series A - ReadCoor
Official Site Inspections
http://www.readcoor.com
- Host name: 104.21.66.134
- IP address: 104.21.66.134
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "ReadCoor"
ReadCoor - Crunchbase Company Profile & Funding
ReadCoor is a technology company offering the first true spatial multi-omic platform to the global audience of researchers, clinicians, pharma and diagnostics companies to expand …See details»
ReadCoor Inc. | Devex
ReadCoor is commercializing a new generation sequencing platform that enables researchers to perform high throughput RNA-Seq while preserving sample morphology and simultaneously …See details»
ReadCoor Company Profile 2024: Valuation, Investors ... - PitchBook
Provider of a panomic spatial sequencing platform designed for researchers, clinicians, pharma and diagnostics companies to help in multi-omic spatial sequencing.See details»
ReadCoor - VentureRadar
ReadCoor is leading the next generation of 'omics' by delivering the first panomic spatial sequencing platform to the global audience of researchers, clinicians, pharma and diagnostics …See details»
ReadCoor, Inc. Company Profile | Pleasanton, CA | Competitors ...
Find company research, competitor information, contact details & financial data for ReadCoor, Inc. of Pleasanton, CA. Get the latest business insights from Dun & Bradstreet.See details»
Document - SEC.gov
PLEASANTON, Calif. October 5, 2020 – Continuing on its mission of mastering biology to advance human health, 10x Genomics, Inc. (Nasdaq: TXG) today announced that it has …See details»
10x Genomics Signs Agreement to Acquire ReadCoor
Oct 7, 2020 · 10x Genomics, Inc. (Nasdaq: TXG) today announced that it has entered into a definitive agreement to acquire ReadCoor, Inc., for cash and stock consideration of $350 million. The announcement follows 10x Genomics’ …See details»
10x Genomics sequences in situ | Nature Biotechnology
Nov 3, 2020 · ReadCoor was spun out of George Church’s lab at Harvard University’s Wyss Institute for Biologically Inspired Engineering. Its core technology, fluorescence in situ …See details»
10x Genomics to Acquire ReadCoor for $350M, Cartana for $41.2M
Oct 5, 2020 · 10x has entered into a definitive agreement to buy Boston-based ReadCoor, a spinout from George Church's laboratory at Harvard Medical School and the Wyss Institute, …See details»
10X Genomics acquires ReadCoor - 2020-10-05 - Crunchbase
Oct 5, 2020 · ReadCoor Leader in true multi-omic spatial sequencing Acquiring Organization: 10X Genomics 10X Genomics ELV solutions and security systems company that provides an …See details»
ReadCoor Company Profile - Office Locations, Competitors ... - Craft
ReadCoor’s is a company developing a spatial sequencing platform, Fluorescent in situ Sequencing (FISSEQ), that produces readouts and 3D images for disease diagnosis.See details»
Exclusive: How Sequencing Firm ReadCoor Came to be Acquired …
Oct 11, 2020 · ReadCoor’s technology links sequencing information and its location, collecting more than tissue and cellular structural information. It also supplies genomics (DNA), …See details»
ReadCoor, Inc. Unveils True Spatial Sequencing Platform to Drive ...
ReadCoor is a technology company offering the first true spatial multi-omic platform to the global audience of researchers, clinicians, pharma and diagnostics companies to expand …See details»
Analysis: 10x Genomics acquires ReadCoor for $350m - Global …
Oct 12, 2020 · ReadCoor’s proprietary Fluorescent in situ Sequencing technology, combines next-generation sequencing technology and high-resolution tissue imaging. ReadCoor is part of the …See details»
Method of the Year: spatially resolved transcriptomics
Jan 6, 2021 · Nature Methods has crowned spatially resolved transcriptomics Method of the Year 2020. Starry skies invite space exploration. In transcriptomics, spatial resolution opens up new …See details»
ReadCoor Raises $27M to Advance Disease Diagnosis and Treatment
Jan 15, 2020 · ReadCoor, a spatial genomic startup working to advance clinical research and drug discovery, announced Tuesday it raised $27 million in Series B financing, bringing its …See details»
ReadCoor spins from Harvard after pulling in $23 million in first …
Oct 4, 2016 · ReadCoor has entered into a worldwide licensing agreement with Harvard's Office of Technology Development, securing exclusive rights to FISSEQ technology. [Also: Big data, …See details»
ReadCoor, Inc. Unveils True Spatial Sequencing Platform to Drive ...
Mar 1, 2024 · ReadCoor, Inc. unveils its first product line, including multi-omic spatial sequencing assays and the RC2 instrument. The platform is powered by ReadCoor’s proprietary FISSEQ …See details»
ReadCoor, Inc. Unveils True Spatial Sequencing Platform to Drive ...
Feb 24, 2020 · ReadCoor is a technology company offering the first true spatial multi-omic platform to the global audience of researchers, clinicians, pharma and diagnostics companies …See details»
ReadCoor will commercialize the Wyss Institute’s (FISSEQ ... - RNA …
ReadCoor, Inc., today announced completion of an oversubscribed $23 million Series A financing round and its concurrent launch from Harvard University’s Wyss Institute for Biologically …See details»